Lineage Cell Therapeutics
LCTX
#8903
Rank
C$0.14 B
Marketcap
$0.64
Share price
-6.12%
Change (1 day)
-58.40%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -C$29.58 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are C$9.49 Million. , an increase over its 2023 earnings that were of -C$34.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 -C$29.71 Million-13.16%
2023 -C$34.21 Million9.83%
2022 -C$31.15 Million-54.24%
2021 -C$68.07 Million86.07%
2020 -C$36.58 Million-31.97%
2019 -C$53.77 Million-5.42%
2018 -C$56.85 Million1.1%
2017 -C$56.24 Million-31.06%
2016 -C$81.57 Million-10.38%
2015 -C$91.02 Million29.69%
2014 -C$70.18 Million31.68%
2013 -C$53.3 Million
2011 -C$25.87 Million89.78%
2010 -C$13.63 Million206.06%
2009 -C$4.46 Million-0.58%
2008 -C$4.48 Million164.89%
2007 -C$1.7 Million-30.22%
2006 -C$2.43 Million
2002 -C$2.82 Million-41.04%
2001 -C$4.78 Million-32.04%
2000 -C$7.03 Million-11.85%
1999 -C$7.97 Million
1997 -C$5.12 Million12.12%
1996 -C$4.57 Million106.25%
1995 -C$2.22 Million-11.11%
1994 -C$2.49 Million50%
1993 -C$1.66 Million20%
1992 -C$1.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.2 Billion 565.31%๐Ÿ‡บ๐Ÿ‡ธ USA